Clinical Trials of Convalescent Plasma Therapy in Indonesia are Phase 2-3, What Are the Targets? All pages
/data/photo/2020/08/18/5f3ba04f8e492.jpg "Clinical Trials of Convalescent Plasma Therapy in Indonesia are Phase 2-3, What Are the Targets? All pages")
KOMPAS.com– Development therapy plasma convalescent at Indonesia has entered phase 2-3, namely assessing the efficacy or benefit (efficacy) of the administration convalescent plasma against Covid-19 patients. This was conveyed by the Deputy Head of Translational Research at the Institute of Molecular Biology (LBM) Eijkman, Prof. Dr. David H Muljono SpPD FINSASIM FAASLD PhD. David explained, … Read more